Bristol-Myers Squibb Company

Stock Chart, Company Information, and Scan Results

$61.98(as of Feb 6, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Bristol-Myers Squibb Company Company Information, Fundamentals, and Technical Indicators

Stock Price$61.98
Ticker SymbolBMY
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - General
Employees34,100
CountyUSA
Market Cap$121,168.0M
EBIDTA19,217.0M
10-Day Moving Average56.51
P/E Ratio20.92
20-Day Moving Average55.99
Forward P/E Ratio9.65
50-Day Moving Average53.71
Earnings per Share2.97
200-Day Moving Average47.56
Profit Margin18.01%
RSI78.19
Shares Outstanding2,035.8M
ATR1.40
52-Week High62.05
Volume17,115,931
52-Week Low41.88
Most Recent Support Level54.21
Book Value18,600.0M
Most Recent Resistance Level56.12
P/B Ratio6.79
Upper Keltner59.14
P/S Ratio2.63
Lower Keltner52.85
Debt-to-Equity Ratio59.14
Next Earnings Date04/30/2026
Cash Surplus-12,410.0M
Next Ex-Dividend DateUnknown

BMY takes the fight against disease to the heart, with leading cardiovascular medications like Camzyos—an FDA-approved treatment for obstructive hypertrophic cardiomyopathy. The global biopharmaceutical company is also well-known for its development of oncology and immunology products, including Opdivo and Yervoy for cancer treatment, and Orencia for rheumatoid arthritis. If you are looking to add a well-diversified biopharmaceutical stock to your portfolio, BMY could be the one.

Bristol-Myers Squibb Company In Our Stock Scanner

As of Feb 06, 2026
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.